Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? (Q34088731)

30 July 2017

1 reference

title

Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? (English)

1 reference

amyotrophic lateral sclerosis

30 July 2017

0 references

0 references

author

Jean-Martin Beaulieu

series ordinal

2

1 reference

30 July 2017

Julien JP

1

1 reference

30 July 2017

publication date

1 November 2000

1 reference

Journal of the Neurological Sciences

30 July 2017

published in

1 reference

30 July 2017

volume

180

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

7-14

1 reference

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Proximal axonal enlargement in motor neuron disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Nitration of the low molecular weight neurofilament is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Peripherin, a new member of the intermediate filament protein family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

A type III intermediate filament gene is expressed in mature neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament protein (NF-L), during the development of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Regulation of peripherin and neurofilament expression in regenerating rat motor neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Peripherin expression in hippocampal neurons induced by muscle soluble factor(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: relief of axonopathy resulting from the toxin beta,beta'-iminodipropionitrile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Requirement of heavy neurofilament subunit in the development of axons with large calibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Heterodimeric associations between neuronal intermediate filament proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Pathogenesis of two axonopathies does not require axonal neurofilaments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Late onset of motor neurons in mice overexpressing wild-type peripherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Aging is associated with divergent effects on Nf-L and GFAP transcription in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Impaired neuroglial activation in interleukin-6 deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Neurofilaments in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

No requirement of alpha-internexin for nervous system development and for radial growth of axons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900422-6

10.1016/S0022-510X(00)00422-6

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference